HepaRegeniX’s darizmetinib clears milestone in major liver resection patients, with favorable safety profile and Phase 2a advance lined up.
Link as first comment.
@longevitytech.bsky.social
@longevitytech.bsky.socialHepaRegeniX’s darizmetinib clears milestone in major liver resection patients, with favorable safety profile and Phase 2a advance lined up.
Link as first comment.
@longevitytech.bsky.socialFirst-in-human ER-100 data support dose escalation, with early visual-field signals in two of three glaucoma patients.
Link as first comment.
@americanaging.bsky.socialMIND diet + brain aging 🧠 Framingham study, 1,647 adults, ~12 yrs of MRIs: each 3-pt higher MIND score = slower grey matter loss, ~2.5 yrs of delayed brain aging. Observational, so not proof of cause.
doi.org/10.1136/jnnp...
www.sciencedaily.com/releases/202...
#BrainHealth #GeroScience
@longevitytech.bsky.socialNew Singapore masterclass will give senior leaders three days to turn geroscience, personal data and market evidence into strategy.
Link as first comment.
@longevitytech.bsky.socialThe company says its four-year lifespan screen found 60+ life-extending compounds, and a new advisory board will help chase them.
Link as first comment.
@longevitytech.bsky.socialSix of ten patients in a small trial improved by two or more steps on a severity scale after one treatment, though the data are interim.
Link as first comment.
@americanaging.bsky.socialYour voice may be an aging clock 🎙️ 2,928 adults, 5 Latin American countries: speech that sounds "older" than your age tracked with brain age, epigenetic age & dementia. Cross-sectional data.
www.science.org/doi/10.1126/...
@longevitytech.bsky.socialAged beagle data hint at lower biological age and preliminary muscle changes with SIRT6c treatment, although key readouts remain ahead.
Link as first comment.
@longevitytech.bsky.socialPharma has the podium as Novo and Lilly stop talking about GLP-1 longevity and start measuring it, bringing early aging data to ARDD.
Link as first comment.
@americanaging.bsky.socialStudying cancer, diabetes, or neurodegeneration? You're studying aging 👀 The AGE Early Career Scholars Program: 25 awards, $1,300 travel funding, mentorship + a talk at AGE 2027. Open to undergrads → postdocs.
Deadline: Dec 1 🧬
age.memberclicks.net
@longevitytech.bsky.socialA retrospective study of 345 paired tests found 83.5% of patients improved, held steady or declined slowly, with no control group.
Link as first comment.
#longevity #geroscience #retrospectivestudy #clinicalresearch #biomarkers
@longevitytech.bsky.socialThe maker of sasineprocel, a patient-derived cell therapy, has published its preclinical work in *Cell Stem Cell* as it heads toward Phase 3.
Link as first comment.
#longevity #geroscience #sasineprocel #celltherapy #stemcell
@longevitytech.bsky.social13th Aging Research and Drug Discovery meeting opened with a pitch for prevention and a program building the endpoints the field needs.
Link as first comment.
#longevity #geroscience #agingresearch #drugdiscovery #prevention
@longevitytech.bsky.socialAt ARDD 2026, senior FDA officials sketch how a therapy targeting aging might one day reach approval, revealing that longevity is a priority.
Link as first comment.
@americanaging.bsky.socialNew npj Aging consensus paper: researchers are proposing standardized biomarker data collection for longevity biotech trials — because right now, results from different companies' trials can't even be meaningfully compared 🧬📋
doi.org/10.1038/s415...
#GeroScience #AgingBiomarkers #LongevityBiotech
@americanaging.bsky.socialLongevity biotech raised ~$3.74B across 49 deals in Q1 2026 alone — up 56% YoY. Capital is increasingly targeting the underlying biology of aging itself, not just its symptoms (Forbes, data via Longevity.Technology/PitchBook)
www.forbes.com/sites/darias...
@ucsfaging.bsky.socialBARI spotlight: Margaret Wallhagen co-authors a Nursing Outlook piece on why geroscience is richer with nurses as the table. Trusted messengers. Holistic care. A life-course view of aging.
#nursing #geroscience
www.nursingoutlook.org/article/S002...
@wolverinebear.bsky.socialHow quickly people age during midlife predicted memory lapses 10 years later www.psu.edu/news/researc...
@longevitytech.bsky.socialYounger founder Christin Glorioso on turning a six-month competition into a side-by-side trial of aging clocks.
Link as first comment.
@longevitytech.bsky.socialPostgraduate program aims to turn geroscience, biomarkers and emerging technologies into evidence-based healthspan medicine for physicians.
Link as first comment.
